Jointown Pharmaceutical Group Co Ltd (600998) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.015x

Based on the latest financial reports, Jointown Pharmaceutical Group Co Ltd (600998) has a cash flow conversion efficiency ratio of 0.015x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥528.22 Million ≈ $77.30 Million USD) by net assets (CN¥35.07 Billion ≈ $5.13 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Jointown Pharmaceutical Group Co Ltd - Cash Flow Conversion Efficiency Trend (2007–2024)

This chart illustrates how Jointown Pharmaceutical Group Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Jointown Pharmaceutical Group Co Ltd (600998) total liabilities for a breakdown of total debt and financial obligations.

Jointown Pharmaceutical Group Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Jointown Pharmaceutical Group Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Tel Aviv Stock Exchange TA:TASE	0.131x
Poonawalla Fincorp Limited NSE:POONAWALLA	0.003x
Grandblue Environment Co Ltd SHG:600323	0.085x
PT Trimegah Bangun Persada Tbk JK:NCKL	0.075x
Escorts Kubota Limited NSE:ESCORTS	0.040x
Amneal Pharmaceuticals, Inc. Class A Common Stock NASDAQ:AMRX	21.854x
KENON HLDGS LTD F:76N	0.032x
Huaan Securities Co Ltd SHG:600909	0.085x

Annual Cash Flow Conversion Efficiency for Jointown Pharmaceutical Group Co Ltd (2007–2024)

The table below shows the annual cash flow conversion efficiency of Jointown Pharmaceutical Group Co Ltd from 2007 to 2024. For the full company profile with market capitalisation and key ratios, see Jointown Pharmaceutical Group Co Ltd (600998) market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥33.59 Billion ≈ $4.92 Billion	CN¥3.08 Billion ≈ $451.07 Million	0.092x	-43.44%
2023-12-31	CN¥29.48 Billion ≈ $4.31 Billion	CN¥4.78 Billion ≈ $699.79 Million	0.162x	+16.75%
2022-12-31	CN¥28.69 Billion ≈ $4.20 Billion	CN¥3.99 Billion ≈ $583.31 Million	0.139x	+8.76%
2021-12-31	CN¥27.07 Billion ≈ $3.96 Billion	CN¥3.46 Billion ≈ $506.17 Million	0.128x	-4.96%
2020-12-31	CN¥25.62 Billion ≈ $3.75 Billion	CN¥3.44 Billion ≈ $503.95 Million	0.134x	+6.70%
2019-12-31	CN¥21.97 Billion ≈ $3.21 Billion	CN¥2.77 Billion ≈ $405.03 Million	0.126x	+110.15%
2018-12-31	CN¥20.38 Billion ≈ $2.98 Billion	CN¥1.22 Billion ≈ $178.82 Million	0.060x	+215.75%
2017-12-31	CN¥19.54 Billion ≈ $2.86 Billion	CN¥-1.01 Billion ≈ $-148.09 Million	-0.052x	-244.26%
2016-12-31	CN¥12.01 Billion ≈ $1.76 Billion	CN¥431.26 Million ≈ $63.11 Million	0.036x	-18.91%
2015-12-31	CN¥9.85 Billion ≈ $1.44 Billion	CN¥435.96 Million ≈ $63.79 Million	0.044x	+308.58%
2014-12-31	CN¥8.09 Billion ≈ $1.18 Billion	CN¥-171.68 Million ≈ $-25.12 Million	-0.021x	-181.86%
2013-12-31	CN¥5.34 Billion ≈ $781.30 Million	CN¥138.47 Million ≈ $20.26 Million	0.026x	+133.99%
2012-12-31	CN¥4.84 Billion ≈ $707.64 Million	CN¥-368.93 Million ≈ $-53.99 Million	-0.076x	+4.45%
2011-12-31	CN¥4.30 Billion ≈ $629.75 Million	CN¥-343.61 Million ≈ $-50.28 Million	-0.080x	+69.06%
2010-12-31	CN¥4.00 Billion ≈ $585.15 Million	CN¥-1.03 Billion ≈ $-150.99 Million	-0.258x	+17.27%
2009-12-31	CN¥1.67 Billion ≈ $244.77 Million	CN¥-521.70 Million ≈ $-76.34 Million	-0.312x	-193.12%
2008-12-31	CN¥1.48 Billion ≈ $216.16 Million	CN¥494.75 Million ≈ $72.40 Million	0.335x	+550.37%
2007-12-31	CN¥1.28 Billion ≈ $187.41 Million	CN¥65.95 Million ≈ $9.65 Million	0.051x	--

About Jointown Pharmaceutical Group Co Ltd

SHG:600998 China Medical Distribution

Market Cap

$3.81 Billion

CN¥26.07 Billion CNY

Market Cap Rank

#4266 Global

#749 in China

Share Price

CN¥5.17

Change (1 day)

-0.39%

52-Week Range

CN¥4.85 - CN¥5.60

All Time High

CN¥44.36